Impella-assisted balloon aortic valvuloplasty.
The Impella LP 2.5 left ventricular assist device (Abiomed) is safe and effective for assisting high-risk percutaneous interventions. A 77-year-old woman with severe aortic stenosis, severe coronary artery disease, an ejection fraction of 20%, severe peripheral vascular disease, and other comorbidities presented to a private, tertiary referral hospital with shortness of breath that had been worsening over 2 weeks. The patient underwent a successful, Impella-assisted balloon aortic valvuloplasty (BAV) without complications. Impella support may be considered during BAV in high-risk patients with contraindications for a TandemHeart device (CardiacAssist, Inc.).
Heart Institute, Good Samaritan Hospital, 1225 Wilshire Blvd., Los Angeles, CA 90017-2395, USA.
Daniel J
DJ
Ludeman
Bryan G
BG
Schwartz
Steven
S
Burstein
D000368:Aged; D001021:Aortic Valve / Q000503:physiopathology*; D001024:Aortic Valve Stenosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D002404:Catheterization / Q000379:methods*; D015897:Comorbidity; D003324:Coronary Artery Disease / Q000453:epidemiology; D005260:Female; D006353:Heart-Assist Devices; D006801:Humans; D012307:Risk Factors; D016896:Treatment Outcome